Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
new york blog main
new york top stories
alivecor
allergan
apps
biomedical engineering
biotech
boehringer ingelheim
boston blog main
boston top stories
bristol-myers squibb
business
cancer
clinical data
cloud
companies established in 1891
companies listed on the new york stock exchange
companies of the netherlands
display technology companies
drug discovery
electronics companies
eli lilly
empagliflozin
entrepreneur
europe
europe blog main
europe top stories
extreme
fda
funding daily
future health
genfit
gilead sciences
hardware routers
headphones manufacturers
ibm
indiana blog main
What
marketed
5
×
drug
company
devices
fda
today
track
additional
aggressively
alivecor
alivecor’s
announced
app
approval
approved
belonged
bid
boehringer
card
change
clearance
conditions
connects
control
credit
data
diabetes
didn’t
discovery
disease
doesn’t
ekg
eli
expand
fallen
fatty
funding
gadgets
google’s
halts
Language
unset
Current search:
marketed
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@extremetech.com
5 years ago
IBM Halts Sales of Watson AI For Drug Discovery and Research
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@venturebeat.com
7 years ago
AliveCor raises $30 million for its credit card-sized heart monitor and app
@theverge.com
7 years ago
Google’s OnHub router can now control Philips Hue lights